| Abevmy 25 mg/mL concentrate for solution for infusion EU/1/20/1515/001-005 |
Bevacizumab |
Biosimilar Collaborations Ireland Limited |
— |
| Evfraxy 60 mg solution for injection in pre-filled syringe EU/1/25/1946/001 |
Denosumab |
Biosimilar Collaborations Ireland Limited |
— |
| Fulphila 6 mg solution for injection in pre-filled syringe EU/1/18/1329/001-002 |
Pegfilgrastim |
Biosimilar Collaborations Ireland Limited |
— |
| Hulio EU/1/18/1319/001-007 |
Adalimumab |
Biosimilar Collaborations Ireland Limited |
— |
| Hulio 20 mg solution for injection in pre-filled syringe EU/1/18/1319/009-010 |
Adalimumab |
Biosimilar Collaborations Ireland Limited |
— |
| Kirsty EU/1/20/1506/001-007 |
Insulin aspart |
Biosimilar Collaborations Ireland Limited |
— |
| Nepexto 25 mg solution for injection in pre-filled syringe EU/1/20/1436/001-002 |
Etanercept |
Biosimilar Collaborations Ireland Limited |
— |
| Nepexto 50 mg solution for injection in pre-filled pen EU/1/20/1436/005-006 |
Etanercept |
Biosimilar Collaborations Ireland Limited |
— |
| Nepexto 50 mg solution for injection in pre-filled syringe EU/1/20/1436/003-004 |
Etanercept |
Biosimilar Collaborations Ireland Limited |
— |
| Ogivri 150 mg powder for concentrate for solution for infusion EU/1/18/1341/001 |
Trastuzumab |
Biosimilar Collaborations Ireland Limited |
— |
| Ogivri 420 mg powder for concentrate for solution for infusion EU/1/18/1341/002 |
Trastuzumab |
Biosimilar Collaborations Ireland Limited |
— |
| Semglee 100 units/ml solution for injection in pre-filled pen EU/1/18/1270/001-004 |
Insulin glargine |
Biosimilar Collaborations Ireland Limited |
— |
| Vevzuo 120 mg solution for injection EU/1/25/1945/001-003 |
Denosumab |
Biosimilar Collaborations Ireland Limited |
— |
| Vivlipeg 6 mg solution for injection in pre-filled syringe EU/1/25/1967/001-002 |
Pegfilgrastim |
Biosimilar Collaborations Ireland Limited |
— |
| Yesafili 40 mg/mL solution for injection in pre-filled syringe. EU/1/23/1751/001-002 |
Aflibercept |
Biosimilar Collaborations Ireland Limited |
— |
| Yesintek 130 mg Concentrate for solution for infusion EU/1/24/1892/004 |
Ustekinumab |
Biosimilar Collaborations Ireland Limited |
— |
| Yesintek 45 mg Solution for injection EU/1/24/1892/002 |
Ustekinumab |
Biosimilar Collaborations Ireland Limited |
— |
| Yesintek 45 mg Solution for injection Subcutaneous use EU/1/24/1892/001 |
Ustekinumab |
Biosimilar Collaborations Ireland Limited |
— |
| Yesintek 90 mg Solution for injection EU/1/24/1892/003 |
Ustekinumab |
Biosimilar Collaborations Ireland Limited |
— |